
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Brightness alteration: Difference between revisions
Jump to navigation
Jump to search
>Kaylee m added sentence |
>Josikins Grammatics |
||
Line 3: | Line 3: | ||
'''Brightness alteration''' is a distortion or change in the levels of perceived brightness comprising a person's vision. This usually results in the person's vision becoming darker<ref>Kleinman, J. E., Gillin, J. C., & Wyatt, R. J. (1977). A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts. Schizophrenia Bulletin, 3(4), 562. https://dx.doi.org/10.1093/schbul/3.4.560</ref><ref name="psilocybin">Fischer, R., Hill, R. M., & Warshay, D. (1969). Effects of the psychodysleptic drug psilocybin on visual perception. Changes in brightness preference. Experientia, 25(2), 166-169. https://doi.org/10.1007/BF01899102</ref><ref>Abraham, H. D., & Wolf, E. (1988). Visual function in past users of LSD: Psychophysical findings. Journal of Abnormal Psychology, 97(4), 443. http://dx.doi.org/10.1037/0021-843X.97.4.443</ref> and muted, but could also potentially result in it becoming lighter and more vivid<ref name="psilocybin"/><ref>Baggott, M. J., Coyle, J. R., Erowid, E., Erowid, F., & Robertson, L. C. (2011). Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug & Alcohol Dependence, 114(1), 63-64. https://doi.org/10.1016/j.drugalcdep.2010.09.006</ref> depending on the person's environment and substances they have consumed. | '''Brightness alteration''' is a distortion or change in the levels of perceived brightness comprising a person's vision. This usually results in the person's vision becoming darker<ref>Kleinman, J. E., Gillin, J. C., & Wyatt, R. J. (1977). A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts. Schizophrenia Bulletin, 3(4), 562. https://dx.doi.org/10.1093/schbul/3.4.560</ref><ref name="psilocybin">Fischer, R., Hill, R. M., & Warshay, D. (1969). Effects of the psychodysleptic drug psilocybin on visual perception. Changes in brightness preference. Experientia, 25(2), 166-169. https://doi.org/10.1007/BF01899102</ref><ref>Abraham, H. D., & Wolf, E. (1988). Visual function in past users of LSD: Psychophysical findings. Journal of Abnormal Psychology, 97(4), 443. http://dx.doi.org/10.1037/0021-843X.97.4.443</ref> and muted, but could also potentially result in it becoming lighter and more vivid<ref name="psilocybin"/><ref>Baggott, M. J., Coyle, J. R., Erowid, E., Erowid, F., & Robertson, L. C. (2011). Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug & Alcohol Dependence, 114(1), 63-64. https://doi.org/10.1016/j.drugalcdep.2010.09.006</ref> depending on the person's environment and substances they have consumed. | ||
Brightness alteration can be accompanied by the coinciding effects of [[pupil dilation]] or [[ | Brightness alteration can be accompanied by the coinciding effects of [[pupil dilation]] or [[pupil constriction|constriction]] and [[photophobia]]. It is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of [[hallucinogen|hallucinogenic]] compounds, such as [[psychedelic|psychedelics]], [[dissociative|dissociatives]], and [[cannabinoid|cannabinoids]].</onlyinclude> | ||
===Psychoactive substances=== | ===Psychoactive substances=== | ||
Compounds within our [[psychoactive substance index]] which may cause this effect include: | Compounds within our [[psychoactive substance index]] which may cause this effect include: |
Revision as of 22:12, 18 June 2018

Brightness alteration is a distortion or change in the levels of perceived brightness comprising a person's vision. This usually results in the person's vision becoming darker[1][2][3] and muted, but could also potentially result in it becoming lighter and more vivid[2][4] depending on the person's environment and substances they have consumed.
Brightness alteration can be accompanied by the coinciding effects of pupil dilation or constriction and photophobia. It is most commonly induced under the influence of moderate dosages of hallucinogenic compounds, such as psychedelics, dissociatives, and cannabinoids.
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 2-FEA
- 2-FMA
- 25B-NBOH
- 25C-NBOH
- 25I-NBOH
- 25I-NBOMe
- 3-FPM
- 3C-E
- 3C-P
- 4-AcO-DET
- 4-AcO-MiPT
- 4-HO-DPT
- 4-HO-DiPT
- 4-HO-EPT
- 4-HO-MPT
- 4-HO-MiPT
- 5-MeO-DiPT
- A-PHP
- A-PVP
- Allylescaline
- Amphetamine
- Blue Lotus
- Cannabis
- Cyclazodone
- DET
- DOB
- DOC
- DOI
- DOM
- Datura
- Desoxypipradrol
- Diphenhydramine
- LSM-775
- Lisdexamfetamine
- MET
- MPT
- Memantine
- Methallylescaline
- MiPT
- PARGY-LAD
- PRO-LAD
- Propylhexedrine
- Proscaline
- Βk-2C-B
See also
- Responsible use
- Hallucinogens
- Deliriants
- Subjective effects index
- Psychedelics - Subjective effects
- Dissociatives - Subjective effects
- Deliriants - Subjective effects
External links
References
- ↑ Kleinman, J. E., Gillin, J. C., & Wyatt, R. J. (1977). A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts. Schizophrenia Bulletin, 3(4), 562. https://dx.doi.org/10.1093/schbul/3.4.560
- ↑ 2.0 2.1 Fischer, R., Hill, R. M., & Warshay, D. (1969). Effects of the psychodysleptic drug psilocybin on visual perception. Changes in brightness preference. Experientia, 25(2), 166-169. https://doi.org/10.1007/BF01899102
- ↑ Abraham, H. D., & Wolf, E. (1988). Visual function in past users of LSD: Psychophysical findings. Journal of Abnormal Psychology, 97(4), 443. http://dx.doi.org/10.1037/0021-843X.97.4.443
- ↑ Baggott, M. J., Coyle, J. R., Erowid, E., Erowid, F., & Robertson, L. C. (2011). Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire. Drug & Alcohol Dependence, 114(1), 63-64. https://doi.org/10.1016/j.drugalcdep.2010.09.006